About Secretome Therapeutics
Secretome Therapeutics is a private company based in Dallas, Texas, incorporated in 2018 in Delaware. It has reported $6,854,247 raised in one offering on Form D since February 2023. Its chief executive is Vineet Jindal.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 23, 2022 | Feb 2, 2023 | $6,854,247of $10.8M target | 48 | $142K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Secretome Therapeutics's Form D filed Feb 2, 2023.
AS
Angela Shen
Director
HR
Henrik Rasmussen
Director
VJ
Vineet Jindal
Chief Executive Officer and director
SK
Sunjay Kaushal
Director
WN
William Niland
Director